glutamate release

Class

inhibitor

Glutamate is the principal excitatory neurotransmitter in the brain, and excessive or poorly timed release of it drives the hyperexcitable neuronal firing seen in seizures and contributes to mood instability. One therapeutic strategy is to dampen this release at its source, in the nerve terminal, rather than blocking glutamate receptors directly, which would broadly interfere with normal excitatory signaling needed for learning, memory, and everyday brain function. Drugs with this mechanism typically act on voltage-gated ion channels in the presynaptic membrane, reducing the likelihood that an arriving nerve impulse triggers the burst of neurotransmitter release characteristic of runaway electrical activity. Lamotrigine, a small molecule, exemplifies this approach: by stabilizing channels involved in the initiation of nerve impulses, it reduces repetitive, high-frequency firing and the resulting excessive glutamate release without abolishing normal synaptic transmission. This mechanism is central to epilepsy, where uncontrolled neuronal firing causes seizures, and it also has relevance in bipolar disorder, where dysregulated excitatory neurotransmission is thought to contribute to mood episodes. Because the effect is activity-dependent, acting preferentially on neurons firing abnormally fast, it aims to preserve normal neurological function while limiting pathological hyperexcitability.